MarketCap
Brookdale Senior Living BKD
$ 11.77
0.08%
Facebook
X
Telegram
Brookdale Senior Living Financial Ratios 2025-2007 | BKD
Brief overview of Brookdale Senior Living 's valuation and returns
This overview follows the five latest available observations from 2021 through 2025.
The current valuation set is EV/EBITDA 24.05x (median 17.97x), P/S 1.1x (median 0.41x), P/B 5.92x (median 1.4x). The current ratio basket stands about 140.3% above the five-year base, increasing sensitivity to weak reports.
Capital efficiency is characterized by ROE 5.9%, ROA -4.4%, ROCE -30.2%. The business is not generating positive returns on invested resources. Valuation should be read cautiously until earnings recover.
Price, earnings and growth produce a PEG of 0.35x. A value below one indicates moderate pricing relative to expected growth.
The cash cycle changed only slightly and ended at 6.8 days.
Overall assessment
Brookdale Senior Living 's market premium is not yet supported by strong capital returns, raising valuation risk.
Annual Financial Ratios Brookdale Senior Living
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-13.4 | -6.3 | -6.6 | -2.7 | -9.9 | 11.1 | -4.7 | -2.9 | -3.1 | -6.8 | -6.6 | - | -958.2 | -49.7 | -31.7 | -41.1 | -20.7 | -7.1 | - |
P/S |
1.1 | 0.4 | 0.4 | 0.2 | 0.4 | 0.3 | 0.3 | 0.3 | 0.4 | 0.6 | 0.6 | - | 1.2 | 1.2 | 0.9 | 0.9 | 0.7 | 1.4 | - |
EPS |
-1.1 | -0.9 | -0.8 | -1.2 | -0.5 | 0.5 | -1.4 | -2.8 | -3.1 | -2.2 | -2.5 | -1.0 | -0.0 | -0.5 | -0.6 | -0.4 | -0.6 | - | - |
EV (Enterprise Value) |
9.23 B | 7.08 B | 6.14 B | 5.59 B | 6.25 B | 6.54 B | 7.52 B | 6.6 B | 7.71 B | 9.68 B | 10.5 B | 9.45 B | 7.09 B | 6.86 B | 5.56 B | 5.44 B | 4.87 B | 2.6 B | -101 M |
EBITDA per Share |
1.63 | 1.82 | 1.64 | 1.63 | 0.69 | 1.46 | 2.08 | 2.74 | 3.54 | 4.06 | 3.85 | - | 3.34 | 2.88 | 3.08 | 3.05 | 2.8 | 0.45 | - |
EV/EBITDA |
24.0 | 17.1 | 16.7 | 18.0 | 49.1 | 12.1 | 11.8 | 9.3 | 8.3 | 8.1 | 9.7 | - | 14.6 | 16.7 | 12.1 | 14.9 | 15.7 | 56.8 | - |
PEG |
-0.79 | -0.48 | -1.1 | -1.9 | 0.35 | -0.66 | -0.1 | -0.36 | 0.08 | -0.56 | 0.05 | - | -10.15 | -13.93 | 0.87 | - | - | - | - |
P/B |
-81.0 | 5.9 | 3.1 | 1.1 | 1.4 | 1.1 | 1.8 | 1.5 | 1.2 | 1.3 | 1.2 | 5.7 | 3.4 | 3.3 | 2.1 | 1.9 | 1.3 | - | - |
P/CF |
16.1 | 7.6 | 7.7 | 194.5 | -10.3 | 4.4 | -14.5 | -71.9 | 11.7 | 86.0 | -25.3 | - | 31.6 | 39.6 | 20.0 | 9.0 | 5.8 | 19.4 | - |
ROE % |
586.98 | -95.04 | -46.82 | -40.92 | -14.19 | 10.22 | -38.35 | -51.87 | -37.34 | -19.46 | -18.61 | - | -0.35 | -6.55 | -6.55 | -4.72 | -6.11 | -38.85 | - |
ROA % |
-4.41 | -3.19 | -3.39 | -4.02 | -1.55 | 1.19 | -3.72 | -8.17 | -7.44 | -4.39 | -4.55 | - | -0.08 | -1.41 | -1.53 | -1.10 | -1.42 | - | - |
ROCE % |
-30.16 | 21.90 | 4.56 | -7.33 | -31.01 | -12.17 | 0.13 | 1.17 | 2.68 | 2.74 | -0.25 | - | 3.73 | 2.79 | 2.73 | 6.10 | 2.75 | -25.00 | - |
Current Ratio |
1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 0.6 | 1.0 | 0.8 | 0.8 | 0.6 | 0.4 | 0.3 | 0.3 | 0.5 | 1.3 | 1.3 | - | - |
DSO |
6.8 | 5.9 | 6.3 | 6.9 | 10.6 | 12.5 | 12.0 | 10.8 | 9.9 | 10.4 | 10.6 | - | 13.2 | 13.2 | 14.7 | 13.5 | 7.0 | - | - |
DPO |
- | - | - | - | - | - | 12.0 | 10.0 | 9.6 | 8.0 | 13.3 | - | 11.9 | 8.1 | 13.1 | - | - | - | - |
Operating Cycle |
6.8 | 5.9 | 6.3 | 6.9 | 10.6 | 12.5 | 12.0 | 10.8 | 9.9 | 10.4 | 10.6 | - | 13.2 | 13.2 | 14.7 | 13.5 | 7.0 | - | - |
Cash Conversion Cycle |
6.8 | 5.9 | 6.3 | 6.9 | 10.6 | 12.5 | 0.0 | 0.8 | 0.3 | 2.4 | -2.7 | - | 1.2 | 5.2 | 1.6 | 13.5 | 7.0 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Brookdale Senior Living
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q4 | 2010-Q3 | 2010-Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.18 | -0.03 | - | -0.48 | -0.18 | -0.28 | - | -0.22 | -0.17 | -0.13 | - | -0.22 | -0.02 | -0.2 | - | -0.15 | -0.45 | -0.54 | - | 0.94 | -0.45 | -0.59 | - | -0.68 | -0.65 | 2.01 | -0.49 | -0.42 | -0.3 | -0.23 | 0.7 | -0.2 | -0.88 | -2.45 | 0.08 | -2.22 | -0.25 | -0.68 | -1.45 | -0.28 | -0.19 | -0.26 | -0.94 | -0.37 | -0.46 | -0.71 | -0.58 | -0.23 | -0.03 | -0.02 | -0.01 | -0.01 | -0.04 | 0.03 | -0.2 | -0.54 | -0.54 | -0.09 | -0.12 | -0.06 | -0.28 | -0.1 | - | - | - |
EBITDA per Share |
0.46 | 0.54 | - | 0.17 | 0.46 | 0.54 | - | 0.44 | 0.47 | 0.48 | - | 0.35 | 0.56 | 0.42 | - | 0.57 | 0.28 | 0.18 | - | 1.13 | 0.64 | 0.13 | - | 1.21 | 0.69 | 0.58 | -0.22 | 1.44 | 0.79 | 0.61 | -0.24 | 1.88 | 0.53 | -1.58 | 0.01 | 0.13 | 1.52 | 0.96 | -0.94 | 2.4 | 1.74 | 0.92 | -0.05 | 3.31 | 2.19 | 0.57 | -0.4 | 1.6 | 1.44 | 0.86 | 0.24 | 1.99 | 1.37 | 0.88 | 0.09 | 1.86 | 1.27 | 0.78 | 0.16 | 1.95 | 1.4 | 0.71 | - | 1.97 | 1.46 |
ROE % |
1686.81 | 1631.65 | 1619.33 | 1602.09 | -113.39 | -80.44 | -36.15 | -46.04 | -29.64 | -26.84 | -18.96 | -24.72 | -31.11 | -46.96 | -38.72 | -16.77 | -24.58 | -23.88 | -7.19 | -22.80 | -59.55 | 0.18 | 15.76 | 2.63 | 6.98 | 13.81 | -38.48 | -12.44 | -4.82 | -13.09 | -51.85 | -63.77 | -87.17 | -73.95 | -37.33 | -51.23 | -26.68 | -25.37 | -19.46 | -13.63 | -13.91 | -15.65 | -18.61 | -15.22 | -13.72 | -10.40 | -5.17 | -1.57 | -0.38 | -0.78 | -0.35 | -2.73 | -9.30 | -15.46 | -22.48 | -21.46 | -15.49 | -12.11 | -6.64 | -6.78 | -6.97 | -1.20 | - | -1.59 | -0.89 |
ROA % |
-2.33 | -3.77 | -3.66 | -4.51 | -3.29 | -3.13 | -2.08 | -2.92 | -2.14 | -2.20 | -1.67 | -2.14 | -2.67 | -4.18 | -3.42 | -0.80 | -1.60 | -1.84 | -0.25 | -2.06 | -6.40 | 0.22 | 1.83 | 0.56 | 1.28 | 2.22 | -3.72 | -0.42 | 0.10 | -1.69 | -8.17 | -10.01 | -14.82 | -12.87 | -7.44 | -10.55 | -5.72 | -5.50 | -4.39 | -3.21 | -3.33 | -3.78 | -4.55 | -3.84 | -3.51 | -2.70 | -1.43 | -0.42 | -0.09 | -0.17 | -0.08 | -0.58 | -1.98 | -3.30 | -4.80 | -4.61 | -3.35 | -2.69 | -1.55 | -1.58 | -1.63 | -0.28 | - | -0.37 | -0.21 |
ROCE % |
728.36 | 741.54 | 834.11 | 837.60 | 43.40 | 34.38 | 14.22 | 12.94 | 17.08 | 12.92 | 7.79 | 11.69 | 6.41 | -10.16 | -11.60 | -17.76 | -30.17 | -32.47 | -23.54 | -30.42 | -31.76 | -21.38 | -12.52 | -18.71 | -14.73 | -13.71 | -13.18 | -11.54 | -8.28 | -15.31 | -58.32 | -53.59 | -76.88 | -61.40 | -17.64 | -26.40 | -1.18 | -0.34 | -1.50 | 6.73 | 4.58 | 0.02 | -6.72 | -8.94 | -11.63 | -8.81 | -2.95 | 2.60 | 8.46 | 10.19 | 12.86 | 11.07 | 10.17 | 9.25 | 8.12 | 8.83 | 9.20 | 10.08 | 8.54 | 7.47 | 6.88 | 1.12 | - | 0.81 | 2.21 |
Current Ratio |
1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
DSO |
7.4 | 6.9 | - | 6.9 | 6.4 | 6.2 | - | 6.0 | 5.8 | 5.7 | - | 5.8 | 6.1 | 6.6 | - | 6.1 | 6.6 | 6.8 | - | 7.5 | 6.7 | 9.8 | - | 12.3 | 11.5 | 10.9 | 12.4 | 12.1 | 12.0 | 11.7 | 11.4 | 10.9 | 10.6 | 10.1 | 10.1 | 10.0 | 9.9 | 10.2 | 10.7 | 10.4 | 10.3 | 10.3 | 10.6 | 10.6 | 10.6 | 10.7 | 10.9 | 12.6 | 18.3 | 15.5 | 13.0 | 13.1 | 13.3 | 13.1 | 13.1 | 3.3 | 3.3 | 3.3 | 13.4 | 14.6 | 15.4 | 13.9 | - | 13.3 | - |
Operating Cycle |
- | - | - | 6.9 | 6.4 | 6.2 | - | 6.0 | 5.8 | 5.7 | - | 5.8 | 6.1 | 6.6 | - | 6.1 | 6.6 | 6.8 | - | 7.5 | 6.7 | 9.8 | - | 12.3 | 11.5 | 10.9 | 12.4 | 12.1 | 12.0 | 11.7 | 11.4 | 10.9 | 10.6 | 10.1 | 10.1 | 10.0 | 9.9 | 10.2 | 10.7 | 10.4 | 10.3 | 10.3 | 10.6 | 10.6 | 10.6 | 10.7 | 10.9 | 12.6 | 18.3 | 15.5 | 13.0 | 13.1 | 13.3 | 13.1 | 13.1 | 3.3 | 3.3 | 3.3 | 13.4 | 14.6 | 15.4 | - | - | - | - |
Cash Conversion Cycle |
- | - | - | 6.9 | 6.4 | 6.2 | - | 6.0 | 5.8 | 5.7 | - | 5.8 | 6.1 | 6.6 | - | 6.1 | 6.6 | 6.8 | - | 7.5 | 6.7 | 9.8 | - | 12.3 | 11.5 | 10.9 | 12.4 | 12.1 | 12.0 | 11.7 | 11.4 | 10.9 | 10.6 | 10.1 | 10.1 | 10.0 | 9.9 | 10.2 | 10.7 | 10.4 | 10.3 | 10.3 | 10.6 | 10.6 | 10.6 | 10.7 | 10.9 | 12.6 | 18.3 | 15.5 | 13.0 | 13.1 | 13.3 | 13.1 | 13.1 | 3.3 | 3.3 | 3.3 | 13.4 | 14.6 | 15.4 | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Brookdale Senior Living , allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
China
USA
Russia
Germany
Britain
